Company name: Woodstock Biomed
Also known as:
Description: Producer of medical cannabis created to utilize marijuana for medical treatments across Canada. The company’s cannabis are produced in a greenhouse facility and are most supplied to pharmaceutical and horticulturalists, enabling its clients to get a consistent supply of medical marijuana throughout the year.
Industry: Healthcare | Group: Pharmaceuticals and Biotechnology | Code:
Start up capital raised (USD Million):
Business status: Generating Revenue
Revenue (USD Million):
Gross profit (USD Million):
Net income (USD Million)
Earnings before interest, tax, depreciation and amortization (EBITDA):
Financing Status: The company was acquired by Leviathan Cannabis Group (CSE: EPIC) for $15.75 million on June 18, 2018. The total transaction value paid by $750,000 in cash and the remainder in Leviathan common shares. The acquisition will enable the acquirer to expand its medical cannabis production capabilities.
Number of active investors:
Profile last updated: 08-Sep-2018
Last known valuation: 15.75
Last known valuation date: 18-Jun-2018